quinuclidines has been researched along with Thoracic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Isobe, T; Iwamoto, Y; Kaneko, M; Kenmotsu, H; Kikugawa, M; Koizumi, S; Mori, K; Murakami, H; Naito, T; Nakashima, K; Nishiyama, F; Omori, S; Ono, A; Takahashi, T; Wakuda, K; Yokoyama, K | 1 |
| Urba, S | 1 |
1 review(s) available for quinuclidines and Thoracic Neoplasms
| Article | Year |
|---|---|
Radiation-induced nausea and vomiting.
Topics: Abdominal Neoplasms; Dexamethasone; Dose Fractionation, Radiation; Head and Neck Neoplasms; Humans; Isoquinolines; Nausea; Palonosetron; Practice Guidelines as Topic; Quinuclidines; Radiotherapy; Serotonin Antagonists; Thoracic Neoplasms; Vomiting | 2007 |
1 trial(s) available for quinuclidines and Thoracic Neoplasms
| Article | Year |
|---|---|
A Phase II study of palonosetron, aprepitant, dexamethasone and olanzapine for the prevention of cisplatin-based chemotherapy-induced nausea and vomiting in patients with thoracic malignancy.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Aprepitant; Benzodiazepines; Cisplatin; Dexamethasone; Female; Humans; Isoquinolines; Male; Middle Aged; Morpholines; Nausea; Olanzapine; Palonosetron; Quinuclidines; Thoracic Neoplasms; Vomiting | 2017 |